Magnetic Endoscope Imaging in Colonoscopy: Influence on Propofol Dosage
NCT ID: NCT02121704
Last Updated: 2015-11-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
334 participants
INTERVENTIONAL
2014-05-31
2015-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Sedation is used widely during colonoscopy for it has improved the tolerability of the investigation. Most of the patients demand for sedation. In Germany Propofol is recommended as the first-line sedative when endoscopy it is performed in an outpatient setting. The use of Propofol involves the danger of respiratory complications. One reason for the application of Propofol doses is the occurrence of pain during the investigation. We hypothesized that if MEI is used and if loops can be avoided sufficiently lower Propofol doses would be needed. We therefore planned this prospective controlled trial.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Use of Magnetic Endoscopic Imaging for Improving Quality Indicators in Outpatient Colonoscopy
NCT01480830
The Effect of ScopeGuide on the Mental Workload of Endoscopist
NCT02092493
Improving Quality of Colonoscopy Using a 3D-imager
NCT00519129
Use of Magnetic Imaging to Asses the Efficacy of Cap Assisted Colonoscopy in Reducing Looping and Improving Patient Acceptance for the Colonoscopy Procedure
NCT00365534
ColoAssist vs. MEI
NCT01895504
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Controll Group
Patients from the control group will be examined using a CF-HQ 190 EVIS Exera III Advanced Diagnostic Video Colonoscope. The Magnetic Endoscope Imaging (Scope Guide) function WILL NOT BE USED during the investigation.
No interventions assigned to this group
Intervention
Patients from the control group will be examined using a CF-HQ 190 EVIS Exera III Advanced Diagnostic Video Colonoscope. The Magnetic Endoscope Imaging (Scope Guide) function WILL BE USED during the investigation.
Magnetic Endoscope Imaging (Scope Guide)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Magnetic Endoscope Imaging (Scope Guide)
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age \>18 years
* written consent given by patient
* investigation under sedation with propofol
Exclusion Criteria
* age \< 18 years
* pregnant women
* patients denying written consent
* ASA class IV, V and VI
* indication for colonoscopy: emergency (e.g. severe rectal bleeding)
* allergy to propofol
* pre-existing hypotension, bradycardia or hypoxemia
* history of sedation accidents
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Olympus
INDUSTRY
Technical University of Munich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter Klare, MD
Role: PRINCIPAL_INVESTIGATOR
II. Medizinische Klinik, Klinikum rechts der Isar der Technischen Universität München, Germany
Stefan von Delius, MD
Role: STUDY_DIRECTOR
Klinikum rechts der Isar der Technischen Universität München
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
II Medizinische Klinik am Klinikum rechts der Isar der Technischen Universität München
München, Deutschland, Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Klare P, Hartrampf B, Haller B, Schlag C, Geisler F, Abdelhafez M, Einwachter H, Bajbouj M, Schmid RM, von Delius S. Magnetic endoscope imaging for routine colonoscopy: impact on propofol dosage and patient safety - a randomized trial. Endoscopy. 2016 Oct;48(10):916-22. doi: 10.1055/s-0042-110933. Epub 2016 Jul 21.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MEXICO
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.